These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7026073)
1. Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. De Lena M; Varini M; Zucali R; Rovini D; Viganotti G; Valagussa P; Veronesi U; Bonadonna G Cancer Clin Trials; 1981; 4(3):229-36. PubMed ID: 7026073 [TBL] [Abstract][Full Text] [Related]
2. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients]. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583 [TBL] [Abstract][Full Text] [Related]
3. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III]. Bustová I Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435 [TBL] [Abstract][Full Text] [Related]
4. A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. Stearns V; Singh B; Tsangaris T; Crawford JG; Novielli A; Ellis MJ; Isaacs C; Pennanen M; Tibery C; Farhad A; Slack R; Hayes DF Clin Cancer Res; 2003 Jan; 9(1):124-33. PubMed ID: 12538460 [TBL] [Abstract][Full Text] [Related]
5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
6. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer. Asoglu O; Muslumanoglu M; Igci A; Ozmen V; Karanlik H; Ayalp K; Bozfakioglu Y; Kecer M; Parlak M Acta Chir Belg; 2005 Feb; 105(1):62-8. PubMed ID: 15790205 [TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results. Ardavanis A; Scorilas A; Tryfonopoulos D; Orphanos G; Missitzis I; Karamouzis M; Chrysochoou M; Sotiropoulou A; Arnogiannaki N; Ioannidis G; Pissakas G; Rigatos G Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236 [TBL] [Abstract][Full Text] [Related]
8. Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancer. Cummings FJ; Gelman R; Tormey DC; DeWys W; Glick J Cancer Clin Trials; 1981; 4(3):253-60. PubMed ID: 7026074 [TBL] [Abstract][Full Text] [Related]
9. Management of locally advanced and inflammatory carcinoma of the breast. Ackland SP; Bitran JD; Dowlatshahi K Surg Gynecol Obstet; 1985 Oct; 161(4):399-408. PubMed ID: 3901356 [TBL] [Abstract][Full Text] [Related]
10. The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial. Thomas E; Holmes FA; Smith TL; Buzdar AU; Frye DK; Fraschini G; Singletary SE; Theriault RL; McNeese MD; Ames F; Walters R; Hortobagyi GN J Clin Oncol; 2004 Jun; 22(12):2294-302. PubMed ID: 15197190 [TBL] [Abstract][Full Text] [Related]
11. Remission rates in breast cancer treated with preoperative chemotherapy and radiotherapy. Gerlach B; Audretsch W; Gogolin F; Königshausen T; Rohn R; Schmitt G; Dimmerling P; Gripp S; Hartmann KA Strahlenther Onkol; 2003 May; 179(5):306-11. PubMed ID: 12740657 [TBL] [Abstract][Full Text] [Related]
12. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040 [TBL] [Abstract][Full Text] [Related]
13. The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Olson JE; Neuberg D; Pandya KJ; Richter MP; Solin LJ; Gilchrist KW; Tormey DC; Veeder M; Falkson G Cancer; 1997 Mar; 79(6):1138-49. PubMed ID: 9070491 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429 [TBL] [Abstract][Full Text] [Related]
15. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2]. Renner H; van Kampen M Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210 [TBL] [Abstract][Full Text] [Related]
16. Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer. Ingle JN; Ahmann DL; O'Fallon JR; Bisel HF; Rubin J; Kvols LK; Giuliani ER Cancer Treat Rep; 1979; 63(11-12):1701-5. PubMed ID: 526908 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB. Kim R; Osaki A; Tanabe K; Toge T Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565 [TBL] [Abstract][Full Text] [Related]
18. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer. Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316 [TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer. Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]